1996
DOI: 10.1016/0009-8981(95)06185-1
|View full text |Cite
|
Sign up to set email alerts
|

Degradation of glycated hemoglobin by erythrocytic proteolytic enzymes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
2
0

Year Published

1997
1997
2016
2016

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 22 publications
1
2
0
Order By: Relevance
“…27 These proteins may be responsible for the overall increase of proteases, and/or for a decrease of their inhibitors, found in diabetes, which may be associated with the development and progression of vascular complications independently of glycemic control. [28][29][30][31][32] These data are thus in agreement with the increased HSP71 abundance in the fibroblasts from our type 1 diabetic patients with DN.…”
Section: Discussionsupporting
confidence: 91%
“…27 These proteins may be responsible for the overall increase of proteases, and/or for a decrease of their inhibitors, found in diabetes, which may be associated with the development and progression of vascular complications independently of glycemic control. [28][29][30][31][32] These data are thus in agreement with the increased HSP71 abundance in the fibroblasts from our type 1 diabetic patients with DN.…”
Section: Discussionsupporting
confidence: 91%
“…Genetic factors also affect the course of complications produced by long-lasting hyperglycaemia: hyperglycaemia-induced oxidative modifications interplay in a complex way with genes [6,7], and a predisposing genetic background could explain the irreversibility of some glucose-induced damage in susceptible patients [8]. Markers for vascular complications, often apparently independent of glycaemic control, are alterations in proteolytic enzyme action [9,10,11,12] and of their inhibitors [9,13,14]. Such changes include unbalanced hyperactivation of plasma-clotting enzymes [15], but also an overall increase in proteolytic activity in various tissues and biological fluids [10,12].…”
mentioning
confidence: 99%
“…Markers for vascular complications, often apparently independent of glycaemic control, are alterations in proteolytic enzyme action [9,10,11,12] and of their inhibitors [9,13,14]. Such changes include unbalanced hyperactivation of plasma-clotting enzymes [15], but also an overall increase in proteolytic activity in various tissues and biological fluids [10,12]. Thus a higher-than-norOne of the most troublesome aspects of Type 1 (insulin-dependent) diabetes mellitus are early and severe complications, especially those affecting the vascular bed [1], which are the main causes of increased morbidity and mortality in the diabetic population.…”
mentioning
confidence: 99%